| Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia IS Tiong, R Dillon, A Ivey, JA Kuzich, N Thiagarajah, KM Sharplin, CH Kok, ... Blood advances 5 (23), 5107-5111, 2021 | 28 | 2021 |
| Pharmacologic reduction of mitochondrial iron triggers a noncanonical BAX/BAK-dependent cell death S Garciaz, AA Guirguis, S Müller, FC Brown, YC Chan, A Motazedian, ... Cancer Discovery 12 (3), 774-791, 2022 | 20 | 2022 |
| Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding JA Kuzich, S Heynemann, N Geoghegan, C Evelyn, S O'Mahoney, ... Pathology 53 (5), 608-612, 2021 | 15 | 2021 |
| Detection of an IGH-BRAF fusion in a patient with BRAF Val600Glu negative hairy cell leukemia ER Thompson, KJC Lim, JA Kuzich, M McBean, D Westerman, CS Tam, ... Leukemia & Lymphoma 61 (8), 2024-2026, 2020 | 8 | 2020 |
| Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses KL Chan, J Gomez, C Cardinez, N Kumari, CE Sparbier, EYN Lam, ... Cancer cell 40 (10), 1190-1206. e9, 2022 | 7 | 2022 |
| The natural history of npm1mut measurable residual disease (MRD) positivity after completion of chemotherapy in acute myeloid leukemia (AML) S Tiong, R Dillon, A Ivey, CH Kok, JA Kuzich, N Thiagarajah, A Bajel, ... Blood 136, 25-27, 2020 | 4 | 2020 |
| Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’experience from Western Australia JA Kuzich, AP Hutchison, KJC Lim, P Smallbone, K Denning, MP Wright, ... Leukemia & Lymphoma 60 (14), 3417-3425, 2019 | 3 | 2019 |
| T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection JA Kuzich, Y Kankanige, J Guinto, G Ryland, M McBean, E Wong, ... Bone marrow transplantation 56 (10), 2582-2590, 2021 | 2 | 2021 |
| P-051: Inferior outcomes for Multiple Myeloma (MM) patients (pts) harbouring t (11; 14) and the promise of venetoclax, real-world Australian retrospective K Lim, D Talaulikar, J Tan, J Loh, P Puvanakumar, J Kuzich, M Ho, ... Clinical Lymphoma Myeloma and Leukemia 21, S66, 2021 | 1 | 2021 |
| Clinical determinants of T-cell receptor diversity after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia D Ritchie, E Wong, R Koldej, JA Kuzich, P Blombery, GL Ryland, ... Blood 134, 1997, 2019 | 1 | 2019 |
| A Rare Cell State Underpins Diverse Mechanisms of Adaptive Resistance to CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia JA Kuzich, L Talarmain, D Vassiliadis, AA Guirguis, JD Chan, PA Beavis, ... Blood 142, 887, 2023 | | 2023 |
| The prognostic impact of t (11; 14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related … KJC Lim, C Wellard, D Talaulikar, JLC Tan, J Loh, P Puvanakumar, ... EJHaem 4 (3), 639-646, 2023 | | 2023 |
| Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic A Tedjaseputra, JA Kuzich, N Thiagarajah, TC Teh, J McClelland, ... Leukemia & Lymphoma 63 (11), 2731-2734, 2022 | | 2022 |
| Triphenotypic acute leukaemia: the contribution of multimodality laboratory diagnostic techniques E Leitinger, JA Kuzich, S Juneja Pathology 53 (5), 678-680, 2021 | | 2021 |
| ACUTE GRAFT-VERSUS-HOST DISEASE ASSOCIATED CEREBELLITIS DETECTED WITH F-18-FDG-PET/CT K Jewell, J Kuzich, ST Lee, R Trethowan, R Macdonell, A Schwarer INTERNAL MEDICINE JOURNAL 51, 24-25, 2021 | | 2021 |
| Acute graft-versus-host disease associated cerebellitis as the cause of pyrexia of unknown origin detected with 18F-FDG-PET/CT KE Jewell, JA Kuzich, ST Lee, R Trethowan, R Macdonell, AP Schwarer Cancer Treatment and Research Communications 27, 100341, 2021 | | 2021 |
| Significant EBV Reactivation Is Associated with Poorer Overall Survival Due to Increased NRM Post Myeloablative/Reduced Intensity, T-Cell Deplete Allogeneic Stem Cell … AA Prabahran, JA Kuzich, ABM Lim, E Wong, D Ritchie Blood 136, 27, 2020 | | 2020 |
| Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complications JA Kuzich, Y Kankanige, J Guinto, G Ryland, M McBean, E Thompson, ... Biology of Blood and Marrow Transplantation 26 (3), S310-S311, 2020 | | 2020 |
| Prognostic Factors and the Impact of Frontline Therapy in Peripheral T-Cell Lymphoma: A Multicenter Australian Study JA Kuzich, AP Hutchison, K Lim, MPF Wright, G Cull, MF Leahy, ... Blood 130, 1524, 2017 | | 2017 |
